Journal for ImmunoTherapy of Cancer (Nov 2023)

1126 The micellar formulation of the TLR7 agonist MBS8(1V270) potentiates the effects of immune checkpoint inhibitors in vivo

Simon Jensen,
Morten Just Petersen,
Svetlana Panina

Affiliations

Simon Jensen: MoTa Biosciences, Kongens Lyngby, Denmark
Morten Just Petersen: MoTa Biosciences, Kongens Lyngby, Denmark
Svetlana Panina: MoTa Biosciences, Kongens Lyngby, Denmark

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.1126
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal